NEW YORK, Aug. 30, 2006 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) today announced that Douglas Abel, president and chief executive officer of Manhattan Pharmaceuticals, Inc. will be presenting a company update at the Roth Capital Partners 2006 New York Conference on Wednesday, September 6 from 9:30am -- 10:00am EDT. The conference is being held September 6-7, 2006 at the Westin New York at Times Square in New York City.
